What is COPD?

Chronic obstructive pulmonary disease (COPD) is a lung disease that causes difficulty breathing. Symptoms include coughing, fatigue, shortness of breath and wheezing.

Treatment for COPD includes surgery and taking medication. Common drug classes used to treat COPD are beta agonist / corticosteroid combinations, beta agonists, beta-2 agonist / anticholinergic combinations, methylxanthines, mucolytics, PDE4 inhibitors, and methylxanthine / expectorant combinations.

Savings Tips for COPD

  • Recall: COPD Inhaler Combivent Respimat

    August 04, 2015

    Manufacturer Boehringer Ingelheim has issued a voluntary recall of one lot of Combivent Respimat, a popular COPD inhaler. Combivent Respimat is a maintenance inhaler used to help keep airways open to make breathing easier for patients with COPD. It’s made up of a combination of two active ingredients, ipratropium and albuterol.

    This is a class II recall, the most common type of recall, which means that there is a situation where use of the recalled medication may cause temporary or medically reversible adverse health consequences, but the likelihood of serious adverse effects is small. See More

  • New COPD Inhaler Stiolto Respimat Now Approved

    June 12, 2015

    Stiolto Respimat (tiotropium bromide/olodaterol) has just been approved by the FDA for the maintenance treatment of COPD, and should be available in pharmacies soon.

    How does Stiolto Respimat work?
    Stiolto Respimat is a combination of Spiriva Respimat and Striverdi Respimat, with the same two active ingredients.

    Tiotropium bromide (Spiriva Respimat) is an anticholinergic, which relaxes the airways and helps keep them open. See More

  • New Albuterol Inhaler Approved: ProAir Respiclick

    March 31, 2015

    Many of you may be familiar with ProAir HFA, one of three brand-only albuterol inhalers currently available. Now, the FDA has tentatively approved a new dry powder inhaler from TEVA pharmaceuticals that will be known as the ProAir Respiclick.

    When the pharmaceutical company first filed their new drug application (NDA) for the medication, in July of 2014, it was going to be called ProAir Spiromax, but the name has since changed. See More

see all savings tips

Popular COPD Drugs

Popularity Drug Name Drug Class Price
Short-Acting Beta Agonists 8 See Prices
Short-Acting Beta Agonists 58 See Prices
Short-Acting Beta Agonists 60 See Prices
see all 41 drugs

Note: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

COPD Drug Classes

Copyright ©2016 GoodRx, Inc.

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.